The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis
Abstract Objective The prognostic role of the number of cycles of adjuvant chemotherapy (ACT) after total mesorectal excision in stage III and high-risk stage II rectal cancer is unknown. As a result of this, our study was designed to assess the effect of the number of cycles of ACT on the predictio...
Main Authors: | Wei-Wei Chen, Wen-Ling Wang, Hong-Min Dong, Gang Wang, Xiao-Kai Li, Guo-Dong Li, Wang-Hua Chen, Juan Chen, Sai-Xi Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02582-6 |
Similar Items
-
Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery
by: Yahang Liang, et al.
Published: (2024-03-01) -
Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Weisong Xue, et al.
Published: (2023-11-01) -
A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
by: Chao Zhang, et al.
Published: (2021-11-01) -
ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
Development and validation of a new staging system for node‐negative gastric cancer based on recursive partitioning analysis: An international multi‐institutional study
by: Jian‐Xian Lin, et al.
Published: (2019-06-01)